SFTPD and interstitial lung disease: Some serum biomarkers such as Klebs von den Lungen-6 (KL-6) and surfactant protein D (SP-D) have superior diagnostic ability for patients with ILD but the evidence for predicting prognosis is insufficient [16,17,18,19,20,21].